SCHEMBL9030773

SCHEMBL9030773

COC(=S)NCc1ccc(-c2ccccc2C(=O)OC(C)(C)C)cc1.NC(O)=S

nearest known ligand 0.45

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 1/20 0.45
CHRNB4 P30926 1/20 0.45
CHRNA3 P32297 1/20 0.45
CHRNA4 P43681 1/20 0.45
LTB4R2 Q9NPC1 2/20 0.45
BDKRB1 P46663 7/20 0.43
ACHE P22303 1/20 0.42
SLC6A3 Q01959 3/20 0.42
SLC6A4 P31645 2/20 0.42
BRS3 P32247 2/20 0.41
ALDH1A1 P00352 1/20 0.40
LMNA P02545 1/20 0.40
GAA P10253 1/20 0.39
HDAC1 Q13547 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9032066 0.85 GAA (0.48) CHRNB2CHRNB4CHRNA3CHRNA4LTB4R2
SCHEMBL9030770 0.83 IDO1 (0.50) CHRNB2CHRNB4CHRNA3CHRNA4LTB4R2
SCHEMBL7896979 0.83 HDAC1 (0.47) CHRNB2CHRNB4CHRNA3CHRNA4LTB4R2
SCHEMBL9402298 0.81 SLC6A3 (0.46) LTB4R2ACHESLC6A3SLC6A4BRS3
SCHEMBL8958229 0.78 ACHE (0.51) CHRNB2CHRNB4CHRNA3CHRNA4LTB4R2
SCHEMBL489306 0.78 NR1H2 (0.48) LTB4R2ACHESLC6A3SLC6A4BRS3
SCHEMBL8875151 0.78 ACHE (0.48) LTB4R2ACHESLC6A3SLC6A4BRS3
SCHEMBL18475231 0.77 ACHE (0.42) CHRNB2CHRNB4CHRNA3CHRNA4LTB4R2
SCHEMBL841128 0.76 PDCD1 (0.53) CHRNB2CHRNB4CHRNA3CHRNA4LTB4R2
SCHEMBL5924515 0.76 SLC6A3 (0.55) CHRNB2CHRNB4CHRNA3CHRNA4LTB4R2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0412594-B1 Substituted triazolinones, triazolinethiones, and triazolinimines as angiotensin II antagonists MERCK & CO INC (US) 1996-01-03 EP disclosed
US-5411980-A Substituted triazolinones, triazolinethiones, and triazolinimines as angiotensin II antagonists MERCK & CO., INC. (US) 1995-05-02 US disclosed
US-5336778-A Substituted triazoles as angiotensin II antagonists MERCK & CO., INC. (US) 1994-08-09 US disclosed
US-5281614-A Hypotensive agents, glaucoma or angiotensin antagonists MERCK & CO., INC. (US) 1994-01-25 US disclosed
WO-1992020662-A1 ACIDIC ARALKYL TRIAZOLE DERIVATIVES ACTIVE AS ANGIOTENSIN II ANTAGONISTS MERCK & CO., INC. (US) 1992-11-26 WO disclosed
EP-0412594-A2 Substituted triazolinones, triazolinethiones, and triazolinimines as angiotensin II antagonists MERCK & CO. INC. (US) 1991-02-13 EP disclosed
EP-0409332-A2 Substituted triazoles as angiotensin II antagonists MERCK & CO. INC. (US) 1991-01-23 EP disclosed